Orchard Therapeutics

$80$125

Orchard Therapeutics is commercial-stage, fully integrated biopharmaceutical company dedicated to transforming the lives of people affected by rare diseases through ex vivo autologous hematopoietic stem cell, or HSC, gene therapies. The company is working to achieve outcome by utilizing a lentiviral vector to introduce a functional copy of a missing or faulty gene into the patient’s autologous HSCs through an ex vivo process, resulting in a drug product that can then be administered to the patient at the bedside.

Report ID:

UMHE21205

Published:

Jan-2022

Pages:

11

Industry:

HeadQuatered Country:

United Kingdom

Geography:

Clear
  Get a Free Sample
SKU: UMHE21205 Category:
Scope
Table of content
Companies Mentioned

Scope

“Overview of the company and its product offering
Detailed insight into its Strategy, Value, Product Portfolio, and Business Headquarter
Information on its recent developments including collaborations, and expansions among others
Biography of top management”

You can also purchase parts of this report. Do you want to check out a section wise
price list?

“1.    Key Facts of the Company
2.    Company Mission
3.    Company Value
4.    Growth Strategy
5.    Key Products & Services Offered
6.    Infographic
7.    Company Timeline
8.    Executive Team
9.    SWOT Analysis
10.    Key Financials
11. Recent Developments
11.1 Business Expansions & Investments
11.2 Mergers and Acquisitions
11.3 Partnerships”

Companies Mentioned

“SIRION Biotech GmbH
GSK
MolMed”